DMSA Chelation: How It Works, Protocols, and What to Expect
Explore the clinic directoryIn this article
DMSA chelation uses dimercaptosuccinic acid (succimer, brand name Chemet), an oral drug that binds lead, mercury and arsenic so the kidneys can clear them in urine. The FDA label approves it only for children 1 year and older with blood lead above 45 mcg/dL, at 10 mg/kg every 8 hours for 5 days and then every 12 hours for 14 days; adult use for mercury or chronic low-level exposure is off label.
At a Glance
- What it is: DMSA (dimercaptosuccinic acid, brand name Chemet) is an FDA-approved oral chelating agent used to remove heavy metals, particularly lead and mercury, from the body.
- FDA status: Approved for lead poisoning in children. Used off-label for mercury and other heavy metal exposure in adults.
- How it works: DMSA binds to heavy metals in the bloodstream and tissues, forming water-soluble complexes that are excreted through the kidneys.
- Protocol: Typically taken orally in cycles (3 days on, 11 days off in low-dose protocols) to allow mineral replenishment between rounds. The FDA label course is 19 days.
- Cost: $30-$100 per round (oral capsules from compounding pharmacy). Much less expensive than IV chelation.
If you have been told you have elevated heavy metals, whether from a blood test, provoked urine test, or clinical suspicion based on symptoms and exposure history, DMSA chelation is one of the most accessible options for getting those metals out of your body. Unlike IV EDTA chelation, which requires clinic visits, DMSA is taken orally at home under physician supervision.
DMSA has been used medically since the 1950s and was FDA-approved in 1991 for pediatric lead poisoning. It is now widely used off-label by functional and integrative medicine physicians for chronic low-level heavy metal exposure: the kind that shows up as brain fog, fatigue, neuropathy, and immune dysfunction rather than the acute poisoning that sends people to the ER.
The evidence for those two uses is very different. Lowering blood lead in documented lead poisoning is well established; benefit for vague symptoms attributed to low-level metals is not. DMSA is one option within broader chelation therapy, which also includes IV EDTA and DMPS.
Key Takeaways
- DMSA (succimer, Chemet) is an oral chelator that binds lead, mercury and arsenic and is excreted mainly in urine, according to the FDA prescribing information.
- The FDA label approves succimer only for children 1 year and older with blood lead above 45 mcg/dL, as a 19-day course with at least two weeks between courses.
- The Treatment of Lead-Exposed Children trial (Rogan et al., NEJM 2001) found succimer lowered blood lead in 780 children but did not improve cognition or behavior.
- The American College of Medical Toxicology (2010) disapproves of provoked urine testing as a basis for starting or continuing chelation.
- The label lists rash in about 4% of patients, raised liver enzymes in 6 to 10%, and neutropenia, so blood counts and liver tests are monitored during treatment.
What is DMSA (succimer)?
DMSA is meso-2,3-dimercaptosuccinic acid, sold in the US as the 100 mg capsule Chemet and generically called succimer. It is a water-soluble relative of dimercaprol (British anti-Lewisite, or BAL), the older injectable chelator developed for arsenic. Compounding pharmacies also prepare DMSA in smaller capsule strengths for low-dose protocols.
Succimer is a prescription drug. Pediatricians, medical toxicologists and poison control centers use it for lead poisoning, while integrative, functional and naturopathic practitioners prescribe it off label for suspected mercury or mixed metal burden. The FDA prescribing information on DailyMed states that it is not indicated to prevent lead poisoning in a lead-containing environment, so removing the exposure source comes first.
How DMSA Chelation Works
DMSA is a dithiol chelating agent: it has two sulfhydryl groups that form strong bonds with heavy metals. When you take DMSA orally, it enters your bloodstream and binds to circulating metals (primarily lead, mercury, arsenic, and cadmium). The resulting metal-DMSA complex is water-soluble and gets filtered out by your kidneys into urine.
The FDA label reports that in adult men with blood lead of 44 to 96 mcg/dL, 10 mg/kg every 8 hours for 5 days lowered mean blood lead by 72.5%. Blood lead then rebounds as lead moves out of bone, which is why courses are repeated and blood levels are rechecked weekly after a course.
Best for Lead
DMSA has the strongest affinity for lead and is the first-line oral chelator for lead exposure. It effectively reduces blood lead levels and is the only FDA-approved oral chelator for lead poisoning.
Effective for Mercury
DMSA binds both inorganic mercury and methylmercury. Commonly used after dental amalgam removal to clear residual mercury. Some practitioners alternate with DMPS for mercury protocols.
Also Chelates Arsenic & Cadmium
DMSA can bind arsenic and cadmium, though with lower affinity than lead. For arsenic-dominant exposure, DMSA may be combined with other agents depending on the clinical scenario.
Mercury use is off label. According to CDC (MMWR, 2006), the effectiveness of chelation in improving kidney or nervous system symptoms of chronic mercury toxicity has not been established.
DMSA vs Other Chelating Agents
DMSA is the oral, home-based option; EDTA and DMPS are the agents most often given by IV in integrative clinics. The table below compares route, target metals, FDA status and the per-round costs this page already lists.
| Chelator | Route | Best Metals | FDA Status | Cost/Round | Key Advantage |
|---|---|---|---|---|---|
| DMSA | Oral | Lead, mercury | Approved (pediatric lead) | $30-$100 | Home use, well-tolerated |
| DMPS | Oral or IV | Mercury, arsenic | Not FDA-approved (available through compounding) | $50-$200 | Stronger mercury binding |
| EDTA (CaNa2) | IV | Lead, cadmium, general metals | Approved (lead poisoning) | $200-$400/session | Broadest spectrum |
| D-Penicillamine | Oral | Copper, lead | Approved (Wilson’s disease; lead use is off label) | $50-$150 | Best for copper (Wilson’s) |
Calcium disodium EDTA (CaNa2EDTA) is the FDA-approved IV lead chelator; disodium EDTA (Na2EDTA) is a different drug. CDC (2006) linked three deaths from low blood calcium to chelation, with Na2EDTA given in at least two, and described succimer as a weak calcium binder. The FDA label advises against combining succimer with CaNa2EDTA and allows succimer four weeks after an EDTA course. For a fuller comparison, see how IV EDTA chelation works.
Key concept: DMSA does not cross the blood-brain barrier efficiently
DMSA primarily chelates metals from the bloodstream and extracellular space. It has limited ability to cross the blood-brain barrier and remove metals from the central nervous system. For brain-concentrated metals, some practitioners use alpha lipoic acid (which does cross the BBB) in conjunction with DMSA, though this protocol is more aggressive and requires careful supervision.
The FDA label states directly that succimer does not cross the blood-brain barrier and is not indicated for lead encephalopathy, which is treated in hospital with IV agents. The alpha lipoic acid combination comes from practitioner protocols and has not been tested in controlled trials.
The Standard DMSA Protocol
Two different approaches go by the name DMSA protocol. The FDA label regimen is the one used in hospitals and pediatric lead clinics. Most integrative practitioners follow the Andy Cutler protocol or a similar low-dose cycling approach:
Dosing: DMSA is taken at regular intervals (every 3-4 hours, including through the night during active rounds) to maintain stable blood levels. Typical adult dose: 10-25mg per dose, adjusted based on body weight and tolerance.
Round structure:
- On phase: 3 days of DMSA taken every 3-4 hours around the clock
- Off phase: 11 days off to allow the body to replenish essential minerals
- Cycle: Repeat for months to years depending on metal burden
Duration: The number of rounds needed depends on metal exposure levels. Mild exposure may resolve in 10-20 rounds. Chronic, heavy exposure (decades of amalgam fillings, occupational exposure) may require 50-100+ rounds over 1-2 years. These round counts are practitioner estimates, not trial results.
How does the FDA label regimen compare with low-dose cycling?
| Attribute | FDA label regimen (Chemet) | Low-dose cycling (Cutler style) |
|---|---|---|
| Who it is for | Children 1 year and older with blood lead above 45 mcg/dL | Adults with suspected chronic low-level exposure (off label) |
| Dose | 10 mg/kg (350 mg/m2) per dose | 10-25mg per dose |
| Frequency | Every 8 hours for 5 days, then every 12 hours for 14 days | Every 3-4 hours around the clock |
| Course length | 19 days | 3 days on, 11 days off |
| Gap between courses | At least 2 weeks, guided by blood lead | 11 days, repeated for months |
| Evidence base | FDA-reviewed pediatric studies | Practitioner experience, no controlled trials |
The label also states that the safety of uninterrupted dosing longer than 3 weeks has not been established. Before a first dose it calls for a complete blood count, liver enzymes (AST and ALT) and kidney function, and during treatment it recommends weekly blood counts and liver tests.
Critical safety rule: Never take DMSA sporadically
DMSA must be taken on a consistent schedule during active rounds. Missing doses or taking DMSA randomly can mobilize heavy metals without fully chelating them, redistributing metals to organs (including the brain) where they cause more damage than they did in their original storage sites. If you cannot commit to the dosing schedule, do not start a round.
This redistribution concern is the founding principle of the Cutler approach. It is plausible on chemical grounds, but it comes from practitioner reasoning rather than human trials, so follow the schedule your prescriber sets.
Side Effects and Mineral Support
Common side effects:
- GI upset: loose stools, nausea, metallic taste (most common, usually mild)
- Fatigue during rounds (metals being mobilized)
- Mild headache
- Sulfur-smelling urine (normal: DMSA is a sulfur compound)
The FDA label adds less common but more serious reactions. Rash occurs in about 4% of patients and mucocutaneous blistering can grow with each course; liver enzymes rose in 6 to 10% of patients; neutropenia (low white cells) means treatment pauses if the neutrophil count falls below 1,200/mcL. Succimer may cause fetal harm, so pregnancy testing comes first. More detail is in chelation therapy side effects.
Mineral depletion: DMSA binds essential minerals as well as toxic metals, particularly zinc, copper, and iron. Supplementation during off-rounds is critical:
| Mineral | Supplementation | When to Take |
|---|---|---|
| Zinc | 25-50mg/day | Off-round days only (competes with chelation) |
| Magnesium | 400-600mg/day | Can take during and off rounds |
| Vitamin C | 1,000-2,000mg/day | During and off rounds (antioxidant support) |
| Selenium | 200mcg/day | Off-round days |
| Molybdenum | 150-300mcg/day | Both (supports sulfur metabolism) |
Zinc is the mineral with the clearest data. In the label's adult dosing study, zinc excretion doubled during treatment, while succimer had no significant effect on urinary iron, calcium or magnesium. The supplement doses above are practitioner conventions, so confirm them with the prescriber against your own blood work.
How are heavy metals tested before DMSA chelation?
Blood lead is the standard test for lead exposure, and blood or unprovoked urine mercury is used for mercury. Results are compared with population reference values, as described in heavy metal testing options.
Provoked (challenge) urine testing gives a dose of DMSA or DMPS and then collects urine. The American College of Medical Toxicology position statement (2010) disapproves of this test, because chelators raise metal excretion in almost anyone and the results are compared with unprovoked reference ranges. ACMT states that treating on the basis of provoked results may cause harm.
What does the research show about DMSA?
The largest trial is the Treatment of Lead-Exposed Children (TLC) study. According to Rogan and colleagues in the New England Journal of Medicine (2001), 780 children with blood lead of 20 to 44 mcg/dL received up to three 26-day succimer courses or placebo. Succimer lowered blood lead, but at 36 months it did not improve cognition, behavior or neuropsychological scores.
That result shaped practice: chelation for children is reserved for higher lead levels, and lowering exposure matters more. Controlled trials of DMSA for chronic fatigue, brain fog, autism or neuropathy attributed to low-level metals are lacking. CDC (2006) noted that the Institute of Medicine found no scientific evidence that chelation is effective for autism.
Who uses DMSA chelation, and for which conditions?
The approved use is pediatric lead poisoning, usually managed by pediatricians and medical toxicologists. Adults with occupational or environmental lead exposure may also receive succimer from occupational medicine or toxicology specialists; see the lead poisoning treatment guide for the wider care path.
Off-label requests come from people with suspected mercury from amalgam fillings or fish, mixed metal exposure, and symptoms such as brain fog, fatigue and neuropathy. Integrative clinics often place DMSA within a broader toxic exposure treatment plan, sometimes alongside IV therapies. The evidence for this group is thin, so a clear exposure history and baseline testing matter.
What does DMSA chelation cost?
Compounded oral DMSA runs about $30-$100 per round, which makes it much less expensive than IV EDTA at $200-$400 per session. Brand-name Chemet from a standard pharmacy costs considerably more. Consult fees, lab panels and follow-up visits are separate, and insurance coverage for off-label use is uncommon, so most integrative DMSA programs are cash pay.
How to find a clinician for DMSA chelation
Look for a prescriber who orders baseline blood tests, explains whether your use is on label or off label, and schedules liver and blood count monitoring. A well run clinic will not base treatment only on a provoked urine test. You can compare chelation therapy clinics in the directory by location and services.
Listing order in the directory is not paid ranking. Featured slots are labeled and capped, Verified means a clinic completed credential checks rather than paying, and Regenerated.com is free for patients. Inclusion is not an endorsement, so ask each clinic how it handles testing and monitoring.
Frequently Asked Questions
Do I need a prescription for DMSA?
Yes. DMSA (Chemet) is a prescription medication. It is available from standard pharmacies (brand name Chemet, typically expensive) or compounding pharmacies (much more affordable, $30-$100 per round). You need a physician willing to prescribe it: most conventional doctors will prescribe for documented lead poisoning, while integrative and functional medicine doctors are more likely to prescribe for chronic low-level metal exposure, which is off label.
How do I know if DMSA chelation is working?
Repeat blood levels are the most reliable marker: blood lead or blood mercury should fall over treatment, and the FDA label advises weekly blood lead checks after a course because levels rebound. Symptom changes in brain fog, fatigue or neuropathy are worth tracking but are hard to attribute. The American College of Medical Toxicology (2010) advises against using provoked urine tests to judge progress.
Is DMSA safe for long-term use?
Long-term safety is not well studied. The FDA label states that uninterrupted dosing beyond 3 weeks has not been established and recommends at least two weeks between courses. Low-dose cycling for 50-100+ rounds over 1-2 years is common in the chelation community, but the main risks are mineral depletion, rash, liver enzyme rises and neutropenia, so blood counts, liver and kidney function are checked regularly.
Should I remove my amalgam fillings before starting DMSA?
Many mercury chelation practitioners recommend removing amalgam fillings with an IAOMT-trained dentist before starting, using a rubber dam, high-volume suction and supplemental air. The FDA (2020) does not recommend removing intact fillings unless medically necessary, because removal briefly raises mercury vapor exposure. Some practitioners begin chelation with amalgams in place.
Is DMSA the same as succimer and Chemet?
Yes. DMSA, succimer and meso-2,3-dimercaptosuccinic acid are the same compound, and Chemet is the FDA-approved 100 mg capsule brand. Compounded DMSA contains the same active ingredient in custom strengths for low-dose protocols, but compounded products are not FDA-approved. DMPS is a different chelator that is not FDA-approved in the US.
Can DMSA remove mercury or lead from the brain?
No, not directly. The FDA label states that succimer does not cross the blood-brain barrier and is not indicated for lead encephalopathy. DMSA lowers metals in blood and soft tissue, which may slowly reduce stores elsewhere over time. Some practitioners add alpha lipoic acid for brain-concentrated metals, but that combination has not been tested in controlled trials and needs close supervision.
Related Reading
- Chelation Therapy: Complete Guide to Heavy Metal Detox: our full pillar page
- NAD+ IV Therapy: often used alongside chelation for cellular recovery
- Brain Fog Guide: heavy metals are an underdiagnosed cause of cognitive dysfunction
- Small Fiber Neuropathy: toxic exposure is a known cause of SFN
